Skip to main content
. 2023 May 13. Online ahead of print. doi: 10.1016/j.jaad.2023.05.017

Fig 4.

Fig 4

Subgroup analyses of the risk of incident autoimmune and autoinflammatory disease outcomes in COVID-19 cohort compared with the historical control cohort according to types of mRNA vaccines. The forest plot depicts aHRs and 95% confidence intervals (CIs) in individuals with mRNA-based COVID-19 vaccination compared to historical controls. Subgroup analyses stratified by type of mRNA-based COVID-19 vaccine (BNT162b2 or mRNA-1273) are shown. The hazard estimates were adjusted for all 18 covariates used for inverse probability of treatment weighting. Individuals who had already been diagnosed with the target outcome on or before the index date were excluded from each analysis. aHR, Adjusted hazard ratio; CI, confidence interval; COVID-19, coronavirus disease 2019.